Hikal
Trending Articles
Related Content
Media
Acoris and c-LEcta to develop synthetic routes for chiral compounds
<p>Acoris Research, a subsidiary of Hikal, and c-LEcta, a German industrial biotech company, are to collaborate on developing synthetic routes for chiral compounds. The partnership combines the expertise of Acoris in process development and small-scale manufacturing with the biocatalysis technologies of c-LEcta.</p>